Jhpiego works with governments, communities, and development partners to strengthen the capacity of health systems to prevent, detect, and respond to public health threats while ensuring continuity of essential health services.

• Through technical assistance, systems strengthening, digital innovation, and community-centered approaches, we support the Department of Health and local stakeholders in building more responsive, resilient, and equitable health systems in the Philippines.

• Our work in global health security spans disease surveillance and outbreak preparedness, immunization and vaccine confidence, laboratory strengthening, emergency response, continuity of care during crises, and digital health systems that improve service delivery and program accountability.

• By combining evidence-based approaches with local expertise and multisectoral collaboration, we help communities better prepare for current and emerging health threats.

Jhpiego, through the CDC Gabay Bakuna Project, supports the Department of Health (DOH) in strengthening preparedness and response to measles and rubella outbreaks in the Philippines.

• In partnership with development partners, Jhpiego contributed to the development of the Operational Measles Rubella Assessment Tool (OMRAT), the VPD Surveillance Supportive Supervision Guide, and the Clinician Training Manual on Vaccine-Preventable Disease (VPD) Surveillance to strengthen local government and hospital-based surveillance systems. These tools are currently for endorsement and adoption by the DOH Epidemiology Bureau.

• Through the US Centers for Disease Control Viral Hepatitis Project, Jhpiego supported the national Triple Elimination of Mother-to-Child Transmission (TEMTC) agenda for HIV, syphilis, and viral hepatitis, including contributions to the drafting of the national TEMTC Technical Guide.

• Jhpiego also provides technical expertise in strengthening the Philippine Integrated Disease Surveillance and Response (PIDSR) Manual of Procedures and National Surveillance Framework to improve disease monitoring and coordinated response systems nationwide.

Through the HPV Vaccination Acceleration Program Partners Initiative (HAPPI) Flexible Technical Assistance Phase 3, Jhpiego supports the DOH and Department of Education in strengthening HPV vaccination delivery through systems strengthening, policy support, and demand generation strategies.

• The initiative improves interagency coordination, strengthens school-based vaccination delivery, and supports increased HPV vaccine uptake among girls aged 9–10 years old. Jhpiego also supports national campaigns such as Bakuna Eskuwela and contributes to implementation research for continuous program improvement.

• Jhpiego has contributed to key national milestones, including support for single-dose HPV vaccination recommendations, GIS-based prioritization of low-coverage areas, and the development of cervical cancer elimination communication frameworks.

• Using behavioral science approaches, Jhpiego applies Behavioral and Social Drivers (BeSD) tools to understand factors influencing HPV vaccine uptake and translate findings into actionable communication and policy strategies.

• The project also strengthened real-time monitoring through standardized KoboToolbox-based data systems, rapid data validation protocols, and regular coordination mechanisms for timely decision-making.

The Building Resilient and Aware Voices for Empowerment (BRAVE) project aims to integrate cervical cancer prevention, adolescent sexual and reproductive health and rights (SRHR), mental health, and climate resilience in vulnerable areas of the Philippines, with a focus on youth empowerment, community health equity, and systems sustainability. The project operates through three interlinked components:

• In collaboration with the Department of Health and the Navotas City local government, Jhpiego pilots localized technical assistance packages to strengthen capacities to prevent, detect, and respond to public health threats.

• The project strengthens community-based disease surveillance through multisectoral collaboration and community-led signal reporting for early detection and response to outbreaks and environmental health risks.

• Key interventions include localization of Community Event-Based Surveillance and Response (CESR), integration of environmental health signals into reporting systems, development of outbreak preparedness and response manuals, local health network mapping, and continuity planning for essential health services.

• BRAVE-GHS is part of the broader BRAVE Project funded through the Olivia Rodrigo Fund4Good initiative.

• Jhpiego is piloting integrated multi-disease diagnostic approaches in selected sites in the Bicol Region through the MULTI-Dx Project. The initiative will introduce integrated screening and testing modalities for HPV, HIV, tuberculosis, and hepatitis B using centralized laboratory testing systems and hub-and-spoke referral networks powered by Roche Cobas 5800 platforms.

• The Centralized Laboratory Model for HPV Screening (CLAMS) expands access to high-performance HPV DNA testing, strengthens specimen referral systems, and improves screening-to-treatment linkage through centralized laboratory networks and hub-and-spoke service delivery models.

Jhpiego, in partnership with the DOH Cancer Control Division, leads the development of iSCerv, a national digital health platform supporting cervical cancer secondary prevention services in the Philippines.

• iSCerv streamlines patient navigation, specimen referral, reporting, and continuity of care through integrated electronic medical records, real-time dashboards, inventory tracking, and decision-support tools.

• The platform enables longitudinal patient tracking, digitizes screening workflows, improves access to HPV-DNA screening results, and strengthens standardized reporting aligned with national health information systems.

• By improving data visibility and program accountability, iSCerv supports more timely, patient-centered cervical cancer prevention and treatment services nationwide.

The Scale Up Cervical Cancer Elimination with Secondary Prevention Strategy (SUCCESS) Project promotes WHO-aligned cervical cancer screening and builds on government partnerships for sustainable services.

• Backed by Unitaid, Boeing, and Roche, this global project is designed to transition countries from a largely opportunistic cervical cancer screening model to a systematic approach. Jhpiego and the Department of Health incorporate innovations such as HPV testing with self-collection, efficient treatment methods like thermal ablation, and enhanced information dissemination on cervical cancer and prevention technologies.

• Over 45,000 women in the Philippines have accessed life-saving cervical cancer screening and treatment services.